The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in
comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration
pneumonia.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Ampicillin Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination Sulbactam